Ignite Creation Date:
2024-05-06 @ 7:33 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06056999
Status:
RECRUITING
Last Update Posted:
2023-10-19
First Post:
2023-09-21
Brief Title:
New Method to Differentiate Benign and Malignant Pulmonary Nodules
Sponsor:
China-Japan Friendship Hospital
Organization:
China-Japan Friendship Hospital
Study Overview
Official Title:
A New Method to Differentiate Benign and Malignant Pulmonary Nodules by Mass Spectrometry Combined With Artificial Intelligence
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational clinical trial is to establish a new method for differentiating benign and malignant pulmonary nodules by peripheral blood detection in patients with pulmonary nodules 3cm The main questions it aims to answer is How to combine blood metabolomic mass spectrometry detection and artificial intelligence image analysis to establish a new model for differentiating benign and malignant pulmonary nodules Participants will be asked provide 4 mL peripheral blood for the test
Detailed Description:
The aim of this clinical trial is to establish a new method for differentiating benign and malignant pulmonary nodules by the combination of metabolomics analysis and artificial intelligence AI analysis It is expected to improve the accuracy of the identification of benign and malignant pulmonary nodules Patients with clinical suspected malignant pulmonary nodules will be included in this trial The subjects will be divided into three group by CT image presentation 1 pure ground-glass nodule pGGN 2 part-solid nodule PSN 3 solid nodule SN Peripheral blood of subjects will be collected and detected by mass spectrometry to obtain the metabolomic characterization The classification model of each group will be constructed based on the data analysis algorithm by machine learning The diagnostic efficacy of the new model combined with the AI image analysis system for differentiating benign and malignant pulmonary nodules will be analyzed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2023-NHLHCRF-YYPPLC-ZR-02 | OTHER_GRANT | National High Level Hospital Clinical Research Funding | None |